677 related articles for article (PubMed ID: 25903918)
1. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Planche V; Gibelin M; Cregut D; Pereira B; Clavelou P
Eur J Neurol; 2016 Feb; 23(2):282-9. PubMed ID: 25903918
[TBL] [Abstract][Full Text] [Related]
2. [Information processing speed and influential factors in multiple sclerosis].
Zhang ML; Xu EH; Dong HQ; Zhang JW
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment among different clinical courses of multiple sclerosis.
Brissart H; Morele E; Baumann C; Perf ML; Leininger M; Taillemite L; Dillier C; Pittion S; Spitz E; Debouverie M
Neurol Res; 2013 Oct; 35(8):867-72. PubMed ID: 23816638
[TBL] [Abstract][Full Text] [Related]
5. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis.
Rodrigues DN; Paes RA; Vasconcelos CC; Landeira-Fernandez J; Alvarenga MP
Arq Neuropsiquiatr; 2011 Aug; 69(4):590-5. PubMed ID: 21877025
[TBL] [Abstract][Full Text] [Related]
6. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Ruano L; Portaccio E; Goretti B; Niccolai C; Severo M; Patti F; Cilia S; Gallo P; Grossi P; Ghezzi A; Roscio M; Mattioli F; Stampatori C; Trojano M; Viterbo RG; Amato MP
Mult Scler; 2017 Aug; 23(9):1258-1267. PubMed ID: 27738090
[TBL] [Abstract][Full Text] [Related]
7. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS.
Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Reuling IE; Polman CH
Neurology; 2004 Jul; 63(2):335-9. PubMed ID: 15277630
[TBL] [Abstract][Full Text] [Related]
8. Balance performance in three forms of multiple sclerosis.
Soyuer F; Mirza M; Erkorkmaz U
Neurol Res; 2006 Jul; 28(5):555-62. PubMed ID: 16808889
[TBL] [Abstract][Full Text] [Related]
9. Social Cognition Abilities in Patients With Different Multiple Sclerosis Subtypes.
Henry A; Tourbah A; Chaunu MP; Bakchine S; Montreuil M
J Int Neuropsychol Soc; 2017 Sep; 23(8):653-664. PubMed ID: 28656885
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in primary and secondary progressive multiple sclerosis.
Wachowius U; Talley M; Silver N; Heinze HJ; Sailer M
J Clin Exp Neuropsychol; 2005 Jan; 27(1):65-77. PubMed ID: 15814443
[TBL] [Abstract][Full Text] [Related]
12. [Neuropsychology of primary progressive multiple sclerosis].
Paes RA; Alvarenga RM; Vasconcelos CC; Negreiros MA; Landeira-Fernández J
Rev Neurol; 2009 Oct 1-15; 49(7):343-8. PubMed ID: 19774527
[TBL] [Abstract][Full Text] [Related]
13. Employment and absenteeism in working-age persons with multiple sclerosis.
Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
[TBL] [Abstract][Full Text] [Related]
14. Olfactory dysfunction in multiple sclerosis: association with secondary progression.
Silva AM; Santos E; Moreira I; Bettencourt A; Coutinho E; Gonçalves A; Pinto C; Montalban X; Cavaco S
Mult Scler; 2012 May; 18(5):616-21. PubMed ID: 22020420
[TBL] [Abstract][Full Text] [Related]
15. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
[TBL] [Abstract][Full Text] [Related]
16. [The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS)].
Leclercq E; Cabaret M; Guilbert A; Jougleux C; Vermersch P; Moroni C
Geriatr Psychol Neuropsychiatr Vieil; 2014 Sep; 12(3):331-8. PubMed ID: 25245320
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment after three decades of multiple sclerosis.
Smestad C; Sandvik L; Landrø NI; Celius EG
Eur J Neurol; 2010 Mar; 17(3):499-505. PubMed ID: 20050887
[TBL] [Abstract][Full Text] [Related]
18. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
[TBL] [Abstract][Full Text] [Related]
19. The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
Dackovic J; Pekmezovic T; Mesaros S; Dujmovic I; Stojsavljevic N; Martinovic V; Drulovic J
Neurol Sci; 2016 Sep; 37(9):1475-81. PubMed ID: 27207679
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Impairment in Multiple Sclerosis With Regards to Disease Duration and Clinical Phenotypes.
Brochet B; Ruet A
Front Neurol; 2019; 10():261. PubMed ID: 30949122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
